The study conducted to know the use of Silvernova skin cream in patients with selected skin diseases.
- Conditions
- Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2021/01/030388
- Lead Sponsor
- Viridis BioPharma Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
1.Male and female aged 18 to 65 who are suffering from mild or moderate fungal infection like intertrigo, tinea, bullous skin disorders like pemphigus or pemphigoids and intense skin care and repair post cosmetic skin procedures including laser procedures, peels. Based on appearance of lesions, Investigators will have the judgement on fungal infection being mild, moderate, or severe.
2.Willing to give informed consent
1.Patients who are suffering from any major systemic illnesses.
2.Patients Participation in any other clinical trials evaluating investigational pharmaceuticals orbiologics within 3 months or devices within 30 days of admission to the study.
3.Cases with secondary infections will be excluded from this study.
4.Severe cases of fungal infection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method